The Prostatype® Test System was presented for the first time in Sweden at the yearly meeting for urologists and urology nurses at ”Urologidagarna 2014” in Linköping.
The research group of Chunde Li has published a scientific article, defining a stem cell gene signature to estimate the survival of prostate cancer patients.
Peng Z et al., Prostate Cancer Prostatic Dis. 2014 Mar;17(1):81-90.
A poster about the Prostatype® Test System was presented at the Annual Meeting of the Association for Molecular Pathology in Phoenix, Arizona.
Patent application for the Prostatype® Test System was granted in September 2013. Patents are pending in the EU, US & Canada, China and Japan.
Zhuochun Peng presented an abstract about Prostatype® at the European Multidisciplinary Meeting on Urological Cancers (EMUC), in Barcelona. She was awarded the first price for innovative research studies in prostate cancer. The study topped the list of more than 170 submissions from 39 countries.